Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause

M. W. Beckmann; W. Braendle; C. Brucker; M. Dören; G. Emons; F. Geisthövel; L. Kiesel; K. König; I. Naß-Griegoleit; O. Ortmann (federführend); T. Rabe; E. Windler

doi:10.1055/s-2003-38433

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2003; 63(3): 209-212
DOI: 10.1055/s-2003-38433

Empfehlung

Georg Thieme Verlag Stuttgart · New York

Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause

Im Auftrag des Vorstands der Deutschen Gesellschaft für Gynäkologie und GeburtshilfeHormone Therapy in Climactere and Postmenopausal Woman. A Consensus of the DGGGM. W. Beckmann, W. Braendle, C. Brucker, M. Dören, G. Emons, F. Geisthövel, L. Kiesel, K. König, I. Naß-Griegoleit, O. Ortmann, T. Rabe, E. Windler

Abstract

Full Text

References

Literatur (RCTs und Metaanalysen/strukturierte Reviews)

1 Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002; 360 942-944
2 Brown J S, Vittinghoff E, Kanaya A M, Agarwal S K, Hulley S, Foxman B. Heart and Estrogen/Progestin Replacement Study Research Group. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol. 2001; 98 1045-1052
3 Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol. 1998; 92 722-727
4 Grady D, Brown J S, Vittinghoff E, Applegate W, Varner E, Snyder T. the HERS Research Group. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol. 2001; 97 116-120
5 Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995; 85 304-313
6 Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M. et al . for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002; 288 49-57
7 Grimes D A, Lobo R A. Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstet Gynecol. 2002; 100 1344-1353
8 Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998; 280 605-613
9 Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W. et al . for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA. 2002; 288 58-66
10 Humphrey L L, Chan B KS, Sox H C. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Int Med. 2002; 137 273-284
11 Lacey J V, Mink P J, Lubin J I, Sherman M E, Troisi R, Hartge P. et al . Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002; 288 334-341
12 Lethaby A, Farquhar S, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding (Cochrane Review). Cochrane Database Syst Rev 2000 (2); CD 000,402. 2000
13 MacLennan A, Lester S, Moore V. et al .Oral replacement therapy versus placebo for hot flushes. (Cochrane Review). Cochrane Database Syst Rev 2001 (1); CD 002978. 2001
14 MacLennan A, Lester S, Moore V. et al . Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric. 2001; 4 58-74
15 Nelson H D, Humphrey L L, Nygren P, Teutsch S M, Allan J D. Postmenopausal hormone replacement therapy. JAMA. 2002; 288 872-881
16 Rodriguez C, Patel A V, Calle E E, Jacob E J, Thun M J. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA. 2001; 285 1460-1465
17 The ESPRIT team . Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002; 360 2001-2008
18 The Women's Health Initiative Study Group . Design of the Women's Health Initiative Clinical Trial and Observational Study. Controlled Clinical Trials. 1998; 19 61-109
19 Writing Group for the Women's Health Initiative Investigators . Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002; 288 321-333

Prof. Dr. Olaf Ortmann
Prof. Dr. Klaus Diedrich

Klinik für Frauenheilkunde und Geburtshilfe
Med. Universität zu Lübeck

Ratzeburger Allee 160

23538 Lübeck

Email: ortmann@medinf.mu-luebeck.de